1. Home
  2. VERU vs MAXN Comparison

VERU vs MAXN Comparison

Compare VERU & MAXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • MAXN
  • Stock Information
  • Founded
  • VERU 1971
  • MAXN 2019
  • Country
  • VERU United States
  • MAXN Singapore
  • Employees
  • VERU N/A
  • MAXN N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • MAXN Semiconductors
  • Sector
  • VERU Health Care
  • MAXN Technology
  • Exchange
  • VERU Nasdaq
  • MAXN Nasdaq
  • Market Cap
  • VERU 54.6M
  • MAXN 59.1M
  • IPO Year
  • VERU 1990
  • MAXN N/A
  • Fundamental
  • Price
  • VERU $2.88
  • MAXN $3.53
  • Analyst Decision
  • VERU Strong Buy
  • MAXN Sell
  • Analyst Count
  • VERU 3
  • MAXN 1
  • Target Price
  • VERU $33.33
  • MAXN $4.00
  • AVG Volume (30 Days)
  • VERU 182.9K
  • MAXN 93.0K
  • Earning Date
  • VERU 12-15-2025
  • MAXN 12-04-2025
  • Dividend Yield
  • VERU N/A
  • MAXN N/A
  • EPS Growth
  • VERU N/A
  • MAXN N/A
  • EPS
  • VERU N/A
  • MAXN N/A
  • Revenue
  • VERU $16,886,419.00
  • MAXN $176,414,000.00
  • Revenue This Year
  • VERU N/A
  • MAXN $100.37
  • Revenue Next Year
  • VERU N/A
  • MAXN $24.61
  • P/E Ratio
  • VERU N/A
  • MAXN N/A
  • Revenue Growth
  • VERU 337.24
  • MAXN N/A
  • 52 Week Low
  • VERU $2.64
  • MAXN $2.49
  • 52 Week High
  • VERU $14.20
  • MAXN $14.49
  • Technical
  • Relative Strength Index (RSI)
  • VERU 32.50
  • MAXN 46.85
  • Support Level
  • VERU $2.76
  • MAXN $3.30
  • Resistance Level
  • VERU $3.99
  • MAXN $3.66
  • Average True Range (ATR)
  • VERU 0.29
  • MAXN 0.21
  • MACD
  • VERU -0.17
  • MAXN -0.00
  • Stochastic Oscillator
  • VERU 11.23
  • MAXN 36.25

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About MAXN Maxeon Solar Technologies Ltd.

Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, Italy, and Rest of world.

Share on Social Networks: